AngioDynamics launches new access kit for VenaCure EVLT system to treat varicose veins

AngioDynamics (NASDAQ: ANGO) announced today the launch of a new access kit allowing fewer procedure steps and faster procedure time for physicians using the VenaCure EVLT system's NeverTouch® gold-tip laser fiber to treat varicose veins.

“While the VenaCure EVLT system remains the top physician choice in laser vein treatment, improvements like this show our commitment to continuous innovation, we will not rest on our laurels but remain committed to the science and practice of vein management.”

The new .018-inch system for the VenaCure EVLT access kit reduces the number of components involved in gaining access for the procedure. The new kit provides a longer .018 inch nitinol long-access wire. The distal tip on the Trè-Sheath™ dilator is resized to accept a .018 inch nitinol access wire, eliminating the need for a micro-access sheath, as well as the need to exchange wires during the procedure. This ultimately reduces an eight-step process to four.

"One of the advantages physicians get from partnering with AngioDynamics is the exceptional opportunity for clinical success," said Shawn McCarthy, Senior Vice President and General Manager for AngioDynamics. "While the VenaCure EVLT system remains the top physician choice in laser vein treatment, improvements like this show our commitment to continuous innovation, we will not rest on our laurels but remain committed to the science and practice of vein management."

"We have been performing the VenaCure EVLT procedure for more than eight years in our practice and were one of the first centers to use the NeverTouch fiber," said John Golan, MD, North Shore Vascular in Chicago, Ill. "During this time, we have noticed a vast improvement in patient comfort. The simplicity and low profile of the new .018-inch system shortens procedural time and further enhances an already great experience for patients and physicians."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.